1993

1993: Приложение

View or download the full issue PDF (Russian)

https://doi.org/10.18093/0135-5449-1993-S

Basic mechanisms of protection of respiratory organs

A. G. Chuchalin

PDF (Rus)

6-7 123

MAXAGUIN (LOMEFLOXACN): INTERNATIONAL EXPEIENCE OF EXPERIMENTAL AND CLINICAL STUDIES/ THE MATERIALS PROVIDED BY SEARLE’S SPECIALISTS

Structure and Antibacterial Activity of Maxaquin (Lomefloxacin Hydrochloride, a fluorquinolonc group drug ). Literatureg Review

PDF (Rus)

8-14 132

Pharmacokinetic properties of Maxaquin

PDF (Rus)

14-21 96

Use of Maxaquin in treatment of exacerbations of chronic bronchitis

PDF (Rus)

21-25 87

Use of Maxaquin in treatment and prophylaxis of urinary tract 2 infections (U T I)

PDF (Rus)

25-31 91

Clinical efficacy of Maxaquin

PDF (Rus)

31-36 91

Maxaquin safety review

PDF (Rus)

36-40 83

CLINICAL AND EXPERIMENTAL STUDIES MAXAGUIN IN RUSSIA

Study of susceptibility to Maxaquin of clinical strains of microorganisms isolated in patients with wound and burns infections

L. A. Grishina, L. S. Puchkova, V. P. Yakovlev

PDF (Rus)

42-44 94

Antibacterial activity of fluorquinolones with regard to microorganism s ~ pathogens of in-hospital infections in oncological clinis

O. M. Dronova, E. Y. Levinskaya

PDF (Rus)

45-47 113

Susceptibility of clinical strains of bacteria to Maxaquin

E. N. Padeyskaya, T. V. Pushkina, M. V. Pavlova, I. A. Grishina, T. P. Radkevich, O. M. Dronova, E. Y. Levinskciya, O. N. Arakelova, T. Y. Yershova, S. A. Fusova, I. S. Bogatova

PDF (Rus)

47-50 104

Effect of Maxaquin on morphology and ultrastructure of gram -negative bacteria

E. N. Pacleyskaya, L. F. Stebayeva

PDF (Rus)

50-55 113

Mechanism of bactericidal activity of Maxaquin in studies with E.Coli K 12

N. I. Fadeeva, M. V. Shulgina

PDF (Rus)

55-58 136

Toxicological characteristics of Maxaquin

I. V. Golovanova, S. A. Sharova, E. A. Chicherina, N. A. Fedoseev, M. A. Miloserdova, Т. A. Guskova, L. F. Stebaeva, E. N. Padeyskaya

PDF (Rus)

59-62 110

Chemotherapeutic activity of Maxaquin invivo in models of acute bacterial infections in mice

E. N. Padeyskaya, L. D. Shipilova, V. E. Mnatzakanyan

PDF (Rus)

63-67 112

Use of Maxaquin in treatment of exacerbations of chronic bronchitis and focal pneumonias

V. E. Nonikov, O. V. Makarova, M. N. Zubkov, E. N. Gugutzidze

PDF (Rus)

67-71 154

Activity of Maxaquin against mycobacteria in vitro in comparison with other fluorquinolones

E. N. Padeyskaya

PDF (Rus)

71-73 95

Use of Maxaquin in combinations therapy of pulmonary TB

G. B. Sokolova, A. D. Kunichan, V. A. Koryakin, A. V. Ziya, M. N. Shapatava

PDF (Rus)

73-75 99

Taxonomy of pathogens and use of Maxaquin and Ciprofloxacin in treatment of complicated UTI

K. I. Savitskaya, M. F. Trapeznikova, A. G. Nekhorosheva, V. N. Nasonov, V. V. Dutov, A. G. Shanina, V. N. Kalinin

PDF (Rus)

76-80 123

Clinical and laboratory evaluation of Maxaquin efficacy in treatm ent of urogenital infections

V. I. Kisina, G. A. Dmitriev, V. N. Bednova, M. M. Vasiliev, T. I. Navolotskaya

PDF (Rus)

80-82 96

Effect of Maxaquin and Ciprofloxacin on the system of anti-infection resistance of patients with pyelonephritis developing against the background of nephrolithiasis

K. I. Savitskaya, O. E. Solodilova, E. V. Rusanova, A. G. Shanina, V. N. Nasonov

PDF (Rus)

83-87 84

Use of Maxaquin in treatment of recurring urogenital chlamidiosis (clinical/laboratory and electronic microscope studies)

V. V. Delektorskiy, G. N. Yashcova, S. M. Fedorov, T. V. Lebedeva, I. N. Lupan

PDF (Rus)

87-90 99

Use of Maxaquin in treatm ent of sexually-transmitted diseases

K. K. Borisenko, V. I. Zudin, V. I. Kisina, N. A. Sbelekhov

PDF (Rus)

90-91 99

Random ized clinical/laboratory study of Maxaquin efficacy versus ciprofloxacin in treatm ent of patients with skin and soft tissue infections

V. P. Yakovlev, L. A. Blatun, I. A. Grishina

PDF (Rus)

92-95 132

Use of Maxaquin in combination treatm ent of rheumatic diseases

B. S. Belov, S. V. Shubin, V. A. Nasonova, S. I. Soldatova

PDF (Rus)

95-96 85

Activity of Maxaquin in experim ents with models of meningoencephalitis in mice caused by Ps. aeruginosa and Kl. pneumonia

E. D. Shipilova, E. N. Padeyskaya

PDF (Rus)

97-100 111

Dependence of chemotherapeutic efficacy of Maxaquin on chronobiological rhythms of microorganism activity

Т. A. Guskova

PDF (Rus)

101-102 94

Experience of the use of Maxaquin in the clinics of the Novosibirsk city

PDF (Rus)

103 77

Review of clinical and experimental studies of Maxaquin (Lomefloxacin Hydrochloride) in Russia

E. N. Padeyskaya

PDF (Rus)

104-107 86

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International.

ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

PULMONOLOGIYA

MAXAGUIN (LOMEFLOXACN): INTERNATIONAL EXPEIENCE OF EXPERIMENTAL AND CLINICAL STUDIES/ THE MATERIALS PROVIDED BY SEARLE’S SPECIALISTS

CLINICAL AND EXPERIMENTAL STUDIES MAXAGUIN IN RUSSIA

Cookies policy